This morning, Europe has started brighter with the Dax and Cac both in the green, the former by 0.8 per cent. In London, shares are up 0.55 per cent, with insurer and fund manager M&G boosting the ...

Dan Jones and the IC team unpack results from a retailer, what investors can learn from 25 years of volatility, and the ...

Takeovers and mergers are a natural part of life on the market. It makes sense for companies to buy or merge with competitors ...

Arguably, one company that fits this description is speciality polymers manufacturer Victrex (VCT), which is the world’s ...

Sensibly, management has been carefully managing costs and is maintaining tight control over working capital. Net cash ...

Having recently appointed a new chief executive, Raffi Stepanian, the medical technology company is building real sales ...

In terms of the fiscal landscape, the Labour government announced (October 2024) an increase in the tax rate on North Sea oil ...

The figures for the year to 31 March were in line with the prior warning. Revenue grew 1 per cent (2 per cent organically) to £1.93bn, with growth driven by the UK and Australia as US sales fell 13 ...

Led by a team who made their name at turnaround specialist Hilco, the group is acquiring undervalued SME businesses at favourable prices by providing an exit to their founders. Moreover, by focusing ...

Ultimately, a narrowing of the 70 per cent share price discount to NAV is dependent on an improvement in property investment ...

There is certainly scope for further cuts, but it is not a case of ‘what goes up must come down’. The Bank of England has ...

The US drugmaker has stolen a march on Novo Nordisk by bringing a viable oral weight-loss medicine, orforglipron, into successful phase 3 clinical trials. An oral version is the holy grail for drugs ...